MEETINGS - TUV Akademie is organising the following series of seminars for FDA-regulated industries (Germany) October - December 1995:
This article was originally published in Clinica
Executive Summary
TUV Akademie is organising the following series of seminars for FDA-regulated industries in Munich, Germany, later this year: Medical Device Regulatory Affairs (October 17th-18th); Understanding the Medical Device GMP and Regulations (October 19th-20th); General Concepts of Process Validation (November 6th-7th); How to Manage an Inspection by the FDA (November 8th-9th); Fundamentals of Pharmaceutical Regulatory Affairs (December 11th-12th); Understanding the Pharmaceutical GMP and Regulations (December 13th-14th). For further details, contact: Frau Sebert, TUV Akademie, Westendstrasse 199, 80686 Munich, Germany. Tel: +49 (89) 5791 1820. Fax: +49 (89) 5791 2247.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.